Fig. 2From: Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE studyEffects of each treatment on ΔFMD. a ΔFMD in FAS. b ΔFMD in subpopulation of HbA1c at baseline ≥7.0%. *P < 0.05Back to article page